MarketPulse

immunization

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bavarian Nordic's Chikungunya Vaccine Wins Swiss Approval, Expanding Global Market Access

Bavarian Nordic's chikungunya vaccine VIMKUNYA wins Swiss regulatory approval, marking the fourth major authorization in 2025 following FDA, EMA, and MHRA clearances.
BVNRYregulatory approvalinfectious disease
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Infanrix Vaccines Poised for Strong Growth as Emerging Markets Expand Immunization Programs

Infanrix vaccines experience robust growth driven by rising birth rates in emerging economies, expanded immunization programs, and increased vaccine manufacturing investments through 2035.
GSKcold chain logisticsInfanrix